the current study examines the effect of one of these drugs , lovastatin , alone and in combination with cholestyramine on postprandial fat metabolism in five patients with severely elevated ldl-cholesterol and normal triglyceride levels ( less than 1.8 mmol l-1 ) and in five patients with similarly elevated ldl-cholesterol and mildly elevated triglyceride levels ( 1.8 to 2.7 mmol l-1 ) .
C0024027
lovastatin
C0020443
elevated